Novavax, Inc. (NVAX) Social Stream
NOVAVAX INC (NVAX) Price Targets From Analysts
Use the tables below to see what analysts covering NOVAVAX INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-05 | 6 | $305 | $200 | $266.2 | $5.16 | 5058.91% |
| 2021-12-16 | 6 | $305 | $172 | $260.6 | $5.16 | 4950.39% |
| 2021-12-21 | 6 | $305 | $209 | $268 | $5.16 | 5093.8% |
| 2022-01-03 | 6 | $315 | $209 | $270 | $5.16 | 5132.56% |
| 2022-01-24 | 6 | $315 | $150 | $250 | $5.16 | 4744.96% |
| 2022-02-14 | 7 | $315 | $150 | $232 | $5.16 | 4396.12% |
| 2022-02-22 | 7 | $315 | $150 | $223.333 | $5.16 | 4228.16% |
| 2022-02-28 | 7 | $294 | $150 | $215 | $5.16 | 4066.67% |
| 2022-03-02 | 7 | $294 | $150 | $213 | $5.16 | 4027.91% |
| 2022-03-03 | 7 | $250 | $150 | $196 | $5.16 | 3698.45% |
| 2022-04-19 | 7 | $250 | $150 | $194.666 | $5.16 | 3672.6% |
| 2022-05-10 | 7 | $207 | $150 | $186.833 | $5.16 | 3520.79% |
| 2022-05-11 | 7 | $207 | $132 | $178.5 | $5.16 | 3359.3% |
| 2022-06-03 | 8 | $207 | $35 | $154.857 | $5.16 | 2901.1% |
| 2022-06-08 | 8 | $207 | $35 | $151.857 | $5.16 | 2842.97% |
| 2022-07-22 | 7 | $207 | $35 | $147.5 | $5.16 | 2758.53% |
| 2022-08-09 | 7 | $207 | $35 | $140.833 | $5.16 | 2629.32% |
| 2022-08-13 | 7 | $207 | $35 | $125.833 | $5.16 | 2338.62% |
| 2022-09-17 | 7 | $207 | $20 | $123.333 | $5.16 | 2290.17% |
| 2022-09-22 | 7 | $207 | $20 | $105.833 | $5.16 | 1951.03% |
| 2022-10-13 | 7 | $207 | $16 | $88.5 | $5.16 | 1615.12% |
| 2022-10-19 | 7 | $207 | $16 | $81.333 | $5.16 | 1476.22% |
| 2022-11-09 | 6 | $207 | $16 | $81.333 | $5.16 | 1476.22% |
| 2022-11-10 | 6 | $207 | $16 | $78.166 | $5.16 | 1414.84% |
| 2022-12-15 | 7 | $207 | $13 | $77.666 | $5.16 | 1405.16% |
| 2023-01-03 | 7 | $110 | $13 | $61.5 | $5.16 | 1091.86% |
| 2023-02-08 | 7 | $110 | $13 | $55.333 | $5.16 | 972.34% |
| 2023-02-17 | 7 | $110 | $13 | $54 | $5.16 | 946.51% |
| 2023-03-10 | 6 | $110 | $10 | $46.833 | $5.16 | 807.62% |
| 2023-05-10 | 6 | $110 | $10 | $39.333 | $5.16 | 662.27% |
| 2023-07-25 | 6 | $41 | $9 | $22.833 | $5.16 | 342.5% |
| 2023-08-09 | 6 | $41 | $9 | $22.833 | $5.16 | 342.5% |
| 2023-08-10 | 6 | $38 | $9 | $22.333 | $5.16 | 332.81% |
| 2023-09-12 | 6 | $38 | $5 | $21.666 | $5.16 | 319.88% |
| 2023-11-10 | 6 | $38 | $5 | $19.6 | $5.16 | 279.84% |
The Trend in the Analyst Price Target
Over the past 31 months, NVAX's average price target has gone down $280.55.
Over the past 44 weeks, NVAX's average upside potential has been 279.95%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-08 | 7 | 110 | 13 | 55.333 | 10.44 | 430.01% |
| 2023-02-17 | 6 | 110 | 13 | 54.000 | 10.02 | 438.92% |
| 2023-03-10 | 6 | 110 | 10 | 46.833 | 6.52 | 618.3% |
| 2023-05-10 | 6 | 110 | 10 | 39.333 | 8.99 | 337.52% |
| 2023-07-25 | 6 | 41 | 9 | 22.833 | 8.00 | 185.41% |
NVAX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.5 | 3 | 0 | 1 | 1 | 1 | 6 |
The Trend in the Broker Recommendations
Over the past 15 months, NVAX's average broker recommendation rating worsened by 0.5.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, NOVAVAX INC's upside potential (average analyst target price relative to current price) is greater than 4191.96% of them.
- In terms of how NOVAVAX INC fares relative to stocks in the large market cap category, note that its number of analysts covering the stock is higher than 397.42% of that group.
- In the context of stocks in the large market cap category, NOVAVAX INC's variance in analysts' estimates is lower than -3468.31% of them.
- In terms of how NOVAVAX INC fares relative to Pharmaceutical Products stocks, note that its average analyst price target is greater than 3415.28% of that group.
Stocks similar to NOVAVAX INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are NBIX, TECH, and RGEN.
View All Top Stocks by Price Target
Make investment decisions regarding NVAX using the data that counts. Try POWR Ratings for free.